134848-96-7

Basic information

• Product Name: Benzyl 5-Hydroxypentanoate
• Synonyms: Benzyl 5-Hydroxypentanoate;Benzyl 5-hydroxypentanonate
• CAS NO: 134848-96-7
• Molecular Formula: C₁₂H₁₆O₃
• Molecular Weight: 208.25364
• Product Categories: Aromatics, Intermediates, Pharmaceuticals, Intermediates & Fine Chemicals
• Mol File: 134848-96-7.mol
• Article Data: 25

Chemical Properties

• Boiling Point: 314.8±25.0 °C(Predicted)
• Appearance: /
• Density: 1.100±0.06 g/cm3(Predicted)
• Storage Temp.: Hygroscopic, -86°C Freezer, Under inert atmosphere
• Solubility: Acetone (Slightly), Chloroform (Slightly)
• PKA: 15.06±0.10(Predicted)
• Stability: Temperature Sensitive
• CAS DataBase Reference: Benzyl 5-Hydroxypentanoate(CAS DataBase Reference)
• NIST Chemistry Reference: Benzyl 5-Hydroxypentanoate(134848-96-7)
• EPA Substance Registry System: Benzyl 5-Hydroxypentanoate(134848-96-7)

Safety Data

• Hazardous Substances Data: 134848-96-7(Hazardous Substances Data)

Usage

Description

Benzyl 5-Hydroxypentanoate is an organic compound that serves as an intermediate in the synthesis of various biologically active molecules. It is characterized by its unique chemical structure, which allows it to be a key component in the development of pharmaceuticals and other related applications.

Uses

Used in Pharmaceutical Industry:
Benzyl 5-Hydroxypentanoate is used as a synthetic intermediate for the preparation of P2-P1'-linked macrocyclic human renin inhibitors. These inhibitors play a crucial role in the development of medications targeting hypertension and other related conditions by regulating the activity of the human renin enzyme. The compound's ability to be incorporated into complex molecular structures makes it a valuable asset in the design and synthesis of novel therapeutic agents.

Upstream product

• 100-51-6 benzyl alcohol 
• 108-55-4 glutaric anhydride, 
• 100-39-0 benzyl bromide 
• 54322-10-0 glutaric acid monobenzyl ester 
• 110-94-1 1,5-pentanedioic acid 
• 542-28-9 3,4,5,6-tetrahydro-2H-pyran-2-one 
• 34245-49-3 5'-deoxy-5'-methylamino-2',3'-O,O-(1-methylethylidene)adenosine 
• 1927-62-4 tetrahydro-2-(benzyloxy)-2H-pyran 
• 37435-69-1 5-hydroxypentanoic acid sodium salt 
• 100-44-7 benzyl chloride 
• 13392-69-3 valeric acid 

Downstream Products

• 1346933-07-0 benzyl 5-(methanesulfonyl)pentanoate 
• 89855-60-7 5-(dimethylamino)pentanoic acid 
• 1346933-11-6 benzyl 5-(dimethylamino)pentanoate 
• 13099-35-9 17-bromoheptadecanoic acid 
• 134848-94-5 5-oxo-5-(phenylmethoxy)pentyl (2R,3S)-4-cyclohexyl-2-hydroxy-3-<<(2S)-2-<<(1,1-dimethylethoxy)carbonyl>amino>-3-<<(phenylmethoxy)carbonyl>amino>propanoyl>amino>butanoate 
• 134848-68-3 (3R,4S,7S)-4-(cyclohexylmethyl)-7-<-L-phenylalanyl>amino>-3-hydroxy-2,6,10-trioxo-1-oxa-5,9-diazacyclotetradecane 
• 134848-95-6 (3R,4S,7S)-4-(cyclohexylmethyl)-7-<<(1,1-dimethylethoxy)carbonyl>amino>-3-hydroxy-2,6,10-trioxo-1-oxa-5,9-diazacyclotetradecane 
• 216770-60-4 1-O-benzyl-5-O-[1-(4-benzyloxycarbonylbutyl)]-phosphono-L-erythro-pent-2-ulose ethane-1,2-diyl dithioacetal 
• 216770-64-8 1-O-benzyl-5-O-[1-(4-benzyloxycarbonylbutyl)]-phosphono-L-erythro-pent-2-ulose 
• 216770-56-8 1-O-benzyl-5-O-[1-(4-benzyloxycarbonylbutyl)-2-(3-oxobutyl)]-phosphono-L-erythro-pent-2-ulose ethane-1,2-diyl dithioacetal 
• 134848-93-4 5-oxo-5-(phenylmethoxy)pentyl (4S,5R)-4-(cyclohexylmethyl)-2,2-dimethyl-3-<(1,1-dimethylethoxy)carbonyl>-5-oxazolidinecarboxylate 
• 1159408-54-4 5-(((2R,3R,4R,5R,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)oxy)pentanoic acid 

Relevant articles and documents

Photoswitchable NHC-promoted ring-opening polymerizations

The UV-induced photocyclization of a dithienylethene-annulated N-heterocyclic carbene precatalyst enabled photoswitchable ring-opening polymerizations of ε-caprolactone and δ-valerolactone. The polymerizations proceeded efficiently in ambient light, however UV irradiation attenuated the reaction rate (kamb/kUV = 59). Subsequent visible light exposure reversed the photocyclization and restored catalytic activity.

TAU-PROTEIN TARGETING COMPOUNDS AND ASSOCIATED METHODS OF USE

The present disclosure relates to bifunctional compounds, which find utility as modulators of tan protein. In particular, the present disclosure is directed to bifunctional compounds, which contain on one end a VHL or cereblon ligand which binds to the E3 ubiquitin ligase and on the other end a moiety which binds tan protein, such that tan protein is placed in proximity to the ubiquitin ligase to effect degradation (and inhibition) of tan. The present disclosure exhibits a broad range of pharmacological activities associated with degradation/inhibition of tan protein. Diseases or disorders that result from aggregation or accumulation of tan protein are treated or prevented with compounds and compositions of the present disclosure.

Modified oligonucleotides and compound that can be used for synthesizing same

The present disclosure falls within the field of biomedical technology, and in particular relates to modified oligonucleatides and a compound that can be used for synthesizing same and a method for modifying oligonucleotides. The present disclosure also relates to the use of the modified oligonucleotides for preventing and/or treating diseases associated with the liver in a subject.